Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient

MeSH terms

• Aged, 80 and over
• Antiviral Agents / administration & dosage
• Antiviral Agents / adverse effects*
• Betacoronavirus / drug effects
• Betacoronavirus / immunology
• Betacoronavirus / pathogenicity
• COVID-19
• Coronavirus Infections / diagnostic imaging
• Coronavirus Infections / drug therapy
• Coronavirus Infections / pathology*
• Coronavirus Infections / virology
• Drug Combinations
• Eryptosis / drug effects*
• Erythrocytes / drug effects*
• Erythrocytes / pathology
• Erythrocytes / virology
• Humans
• Lopinavir / administration & dosage
• Lopinavir / adverse effects*
• Lung / diagnostic imaging
• Lung / pathology
• Lung / virology
• Male
• Pandemics
• Pneumonia, Viral / diagnostic imaging
• Pneumonia, Viral / drug therapy
• Pneumonia, Viral / pathology*
• Pneumonia, Viral / virology
• Ritonavir / administration & dosage
• Ritonavir / adverse effects*
• SARS-CoV-2
• Tomography, X-Ray Computed